Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Asian Pacific Journal of Cancer Prevention : APJCP|February 18, 2014
Efficacy and safety of an increased-dose of dexamethasone in patients receiving fosaprepitant chemotherapy in JapanHozumi Kumagai, Hitoshi Kusaba, Yuta Okumura, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 2, 2013
Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapyMayako Uchida, Hiroaki Ikesue, Koji Kato, et al.BMC Pulmonary Medicine|July 19, 2026
COPD is associated with poorer survival in patients with advanced non-small cell lung cancer treated with first-line ICI plus chemotherapyAkihisa Takano, Daisuke Shibahara, Hiroaki Ogata, et al.Biological & Pharmaceutical Bulletin|May 22, 2020
Risk Factors for Febrile Neutropenia Induced by Docetaxel Chemotherapy in Patients with Non-small Cell Lung CancerMayako Uchida, Yuki Yamaguchi, Syuhei Hosomi, et al.In Vivo (Athens, Greece)|April 28, 2022
Evaluation of Medication Instruction Sheets for Patients Undergoing R-CHOP Therapy in Non-Hodgkin's LymphomaMayako Uchida, Rika Kawai, Rie Hisamitsu, et al.Journal of Clinical Pharmacy and Therapeutics|September 4, 2021
Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in JapanMasami Tsuchiya, Hideyuki Terazono, Yosuke Maki, et al.Biological & Pharmaceutical Bulletin|July 5, 2022
Evaluation of a Webinar for Pharmacists Learning Basic Clinical-Oncology during COVID-19 Pandemic in JapanHideyuki Terazono, Masami Tsuchiya, Yosuke Maki, et al.Journal of Ethnopharmacology|January 14, 2026
Evaluation of the association of pseudoaldosteronism with licorice-containing herbal medicine using the Japanese Adverse Drug Event Report (JADER) databaseSatoshi Nakao, Jun Liao, Yoko Ino, et al.Cancer Diagnosis & Prognosis|September 6, 2024
Risk Factor for Rash in Patients Receiving Cytarabine and Idarubicin Induction Therapy for Acute Myeloid LeukemiaMayako Uchida, Shigeru Ishida, Erika Mochizuki, et al.Biological & Pharmaceutical Bulletin|August 18, 2020
Risk Factors for Skin Toxicities Associated with Bendamustine-Based Chemotherapy in Patients with Non-Hodgkin LymphomaMayako Uchida, Yasuhiro Mori, Kenta Akiba, et al.Pageof 11